Vaccine News and Research

Latest Vaccine News and Research

Withdrawal of COVID-19 mitigation measures resulted in a rebound in Streptococcus pneumoniae cases in Germany

Withdrawal of COVID-19 mitigation measures resulted in a rebound in Streptococcus pneumoniae cases in Germany

20 Dec 2022
COVID-19 epidemiology can be estimated using blood donation samples

COVID-19 epidemiology can be estimated using blood donation samples

20 Dec 2022
The potential effects of receiving 2 SARS-CoV-2 vaccine doses on household transmission in England

The potential effects of receiving 2 SARS-CoV-2 vaccine doses on household transmission in England

20 Dec 2022
Research uncovers a new way to boost the effectiveness of RNA therapies

Research uncovers a new way to boost the effectiveness of RNA therapies

20 Dec 2022
Study finds a lower mortality rate among individuals with myocarditis after mRNA vaccination than those with viral infection–related myocarditis

Study finds a lower mortality rate among individuals with myocarditis after mRNA vaccination than those with viral infection–related myocarditis

20 Dec 2022
Researchers generate a remodeled live-attenuated measles vaccine capable of driving nAb responses against SARS-CoV-2 spike protein

Researchers generate a remodeled live-attenuated measles vaccine capable of driving nAb responses against SARS-CoV-2 spike protein

20 Dec 2022
The effectiveness of a bivalent COVID-19 mRNA booster dose against hospitalization

The effectiveness of a bivalent COVID-19 mRNA booster dose against hospitalization

20 Dec 2022
Study identifies four new monoclonal antibodies with broad neutralizing potencies that target conserved SARS-CoV-2 epitopes

Study identifies four new monoclonal antibodies with broad neutralizing potencies that target conserved SARS-CoV-2 epitopes

20 Dec 2022
Nasal antibodies decline nine months after COVID-19 infection, study finds

Nasal antibodies decline nine months after COVID-19 infection, study finds

20 Dec 2022
Bivalent mRNA booster vaccines provide greater short-term protection against symptomatic COVID-19 infection

Bivalent mRNA booster vaccines provide greater short-term protection against symptomatic COVID-19 infection

19 Dec 2022
Understanding why young cancer survivors often opt out of HPV vaccination

Understanding why young cancer survivors often opt out of HPV vaccination

19 Dec 2022
Immune-evading Mycobacterium tuberculosis prevents inflammatory responses by hijacking the host’s ubiquitin

Immune-evading Mycobacterium tuberculosis prevents inflammatory responses by hijacking the host’s ubiquitin

19 Dec 2022
Single-dose smallpox vaccine could be effective against mpox

Single-dose smallpox vaccine could be effective against mpox

19 Dec 2022
Milk antibodies against SARS-CoV-2 after booster vaccination and breakthrough infection

Milk antibodies against SARS-CoV-2 after booster vaccination and breakthrough infection

19 Dec 2022
Seasonal influenza activity remains high but appears to be declining in some areas of the US

Seasonal influenza activity remains high but appears to be declining in some areas of the US

19 Dec 2022
The impact of multimorbidity, smoking status, and demographics on vaccine hesitancy among pregnant women in Wales

The impact of multimorbidity, smoking status, and demographics on vaccine hesitancy among pregnant women in Wales

19 Dec 2022
Study demonstrates robust antibody response elicited by trivalent protein subunit vaccine against SARS-CoV-2

Study demonstrates robust antibody response elicited by trivalent protein subunit vaccine against SARS-CoV-2

19 Dec 2022
Rise and waning of SARS-CoV-2 antibody responses induced by mRNA vaccine booster in a healthcare worker population

Rise and waning of SARS-CoV-2 antibody responses induced by mRNA vaccine booster in a healthcare worker population

19 Dec 2022
Safety and immunogenicity of the Omicron BA.4/BA.5-containing bivalent booster mRNA-1273.222

Safety and immunogenicity of the Omicron BA.4/BA.5-containing bivalent booster mRNA-1273.222

19 Dec 2022
Study examines Mpox prevention with modified vaccinia Ankara (MVA)

Study examines Mpox prevention with modified vaccinia Ankara (MVA)

18 Dec 2022

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback